Nanopore (unwinding enzyme)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd306/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd306/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd305/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd305/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd304/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd304/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd303/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd303/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd302/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd302/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd301/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd301/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd300/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd300/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd2ff/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd2ff/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd2fe/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd2fe/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd2fd/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd2fd/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd2fc/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd2fc/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd2fb/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd2fb/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd2fa/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd2fa/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd2f9/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd2f9/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd2f8/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd2f8/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd2f7/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd2f7/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd2f6/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd2f6/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd2f5/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd2f5/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd2f4/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd2f4/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd2f3/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd2f3/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd2f2/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd2f2/5e56c8154b682f00285fd2ee.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e56c89f4b682f00285fd2f1/5e56c8154b682f00285fd2ee.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e56c89f4b682f00285fd2f1/5e56c8154b682f00285fd2ee.png"}]